Optiray 350 Injektionslösung Svizzera - tedesco - Swissmedic (Swiss Agency for Therapeutic Products)

optiray 350 injektionslösung

guerbet ag - jod - injektionslösung - ioversolum 741 mg corresp. iodum 350 mg, trometamoli hydrochloridum, trometamolum, natrii calcii edetas, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 24.5 µg. - röntgenkontrastmittel - synthetika

OPTIRAY 350 Irlanda - inglese - HPRA (Health Products Regulatory Authority)

optiray 350

covidien (uk) commerical limited - ioversol - solution for inj/inf - 350

OPTIRAY 350 PFS Irlanda - inglese - HPRA (Health Products Regulatory Authority)

optiray 350 pfs

covidien (uk) commerical limited - ioversol - solution for injection - 350

OPTIRAY 350 (ULTRAJECT) Solution Canada - francese - Health Canada

optiray 350 (ultraject) solution

liebel-flarsheim company llc - ioversol - solution - 74% - ioversol 74% - roentgenography

Optiray 350 Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

optiray 350

obex medical ltd - ioversol 74% (provides 35% (350mg/ml) organically bound iodine) - solution for injection - 74 % - active: ioversol 74% (provides 35% (350mg/ml) organically bound iodine) excipient: sodium calcium edetate trometamol

OPTIRAY 350 (ULTRAJECT) SOLUTION Canada - inglese - Health Canada

optiray 350 (ultraject) solution

liebel-flarsheim company llc - ioversol - solution - 74% - ioversol 74% - roentgenography

OPTIJECT 350 mg d'I/mL, solution injectable ou pour perfusion Francia - francese - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

optiject 350 mg d'i/ml, solution injectable ou pour perfusion

guerbet - iode 350 mg sous forme de : ioversol 741 mg - solution - 350 mg - pour 1 ml > iode 350 mg sous forme de : ioversol 741 mg - classe pharmacothérapeutique - classe pharmacothérapeutique - code atc : v08ab07.ce médicament est à usage diagnostique uniquement. optiject est utilisé pour plusieurs types d’examens radiographiques, dont : imagerie des vaisseaux (artères et veines) imagerie des reins scanner (tomodensitométrie)optiject est un produit de contraste radiologique contenant de l’iode. l’iode bloque les rayons x, ce qui rend visibles les vaisseaux et les organes internes irrigués par le sang.

OPTIRAY 350- ioversol injection
OPTIRAY 320- ioversol injection
OPTIRAY 300- ioversol injection Stati Uniti - inglese - NLM (National Library of Medicine)

optiray 350- ioversol injection optiray 320- ioversol injection optiray 300- ioversol injection

liebel-flarsheim company llc - ioversol (unii: n3rib7x24k) (ioversol - unii:n3rib7x24k) - ioversol 741 mg in 1 ml - optiray is indicated for: in adults - optiray 300: cerebral arteriography and peripheral arteriography. - optiray 320: cerebral arteriography, peripheral arteriography, visceral and renal arteriography, aortography, coronary arteriography, and left ventriculography. - optiray 350: peripheral arteriography coronary arteriography, and left ventriculography. in pediatric patients - optiray 320 and optiray 350: angiocardiography. in adults - optiray 300: ct imaging of the head and body, venography, and intravenous excretory urography. - optiray 320: ct imaging of the head and body, venography, and intravenous excretory urography. - optiray 350: ct imaging of the head and body, venography, intravenous excretory urography, and intravenous digital subtraction angiography (iv-dsa). - in pediatric patients optiray 320: ct imaging of the head and body, and intravenous excretory urography. symptomatic hyperthyroidism risk summary postmarketing data with optiray use in pregnant women are insufficient to de